Group items tagged

Synchron has launched the first clinical trial of its neural interface technology Stentrode.

The global electronic clinical outcome assessment (eCOA) solutions market is expected to reach USD 2.16 billion by 2025, according to a new report by Grand View Research, Inc. The complexity in healthcare information management is anticipated to fuel the demand for eCOA solutions in coming years. These solutions deliver accurate and timely health information and reduce burden of patients enrolled in clinical trials.eCOA measures overall mental state, patient symptoms, and the progression of a disease. Electronic diaries and electronic Patient Reported Outcomes (ePRO) are a part of eCOA platforms. Electronic diaries help document patient response. These are used as support systems for ePRO. In all the applications of clinical outcome assessment systems, the compliance rates are more than 90%, which helps accelerate research procedures.In addition, assessment systems help detect probable adverse conditions in advance for patients, which is crucial for taking preventive measures to avoid adverse effects in future. The ePRO platforms transfer real-time data from the patients to healthcare professionals for accurate decision-making and better evaluation of a patient's health. Thus, the adoption of these platforms is expected to grow in near future.

Medical Writing is an important part of health practice and our team of specialist medical writers offers the best quality and science standards with reliable, timely, and cost-effective clinical and regulatory materials. Reference : https://pubrica.com/services/physician-writing-services/ Continue Reading: http://bit.ly/3oPrhEY Why Pubrica? When you order our services, Plagiarism free|onTime|outstanding customer support|Unlimited Revisions support|High-quality Subject Matter Experts.   Contact us :      Web: https://pubrica.com/  Blog: https://pubrica.com/academy/  Email: sales@pubrica.com  WhatsApp : +91 9884350006  United Kingdom: +44- 74248 10299

Reports and Insights freshly added a report titled "Chronic Ocular Graft-Versus-Host Disease Market: Opportunity Analysis and Future Assessment 2023-2030" in its database of market research reports which offers its readers a detailed and profound analysis on the fresh growth opportunities, trends and growth drivers that are closely linked with the growth of the market. The report further provides crucial insights on the COVID-19 impacts on the Chronic Ocular Graft-Versus-Host Disease Market along with the compound growth rate (CAGR) of the market for a forecasted period between 2023 and 2030. The report also comprises assessment of the market by employing various analytical tools, such as Porter's five forces analysis and PESTEL analysis. These tools also offer an in-depth analysis on the micro and macro-environmental factors that are related to the growth of the market over the projected period.  The global chronic ocular graft-versus-host disease market in 2020 is accounted for more than US$ xx Bn and expected to reach a value of US$ xx Bn by 2028 with a significant CAGR of 4.2%. Chronic Ocular Graft-Versus-Host Disease Market: https://reportsandinsights.com/sample-request/1225 Chronic Ocular Graft-Versus-Host Disease Market Dynamics The rising prevalence of bone marrow cancers and the increasing number of road accidents among individuals across the globe are the major factors driving the growth of the global chronic ocular graft-versus-host disease market. For instance, according to data published by World Health Organization (WHO), in September 2018, Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 Mn deaths in 2018. Moreover, growing research and development activities on diagnosis management, coupled with a huge new pipeline of drugs are further propelling the growth of the global chronic ocular graft-versus-host disease market. However, factors such as low societal awareness, delayed diagnosis, and low go

Reports and Insights freshly added a report titled "Central Labs Market: Opportunity Analysis and Future Assessment 2022-2030" in its database of market research reports which offers its readers a detailed and profound analysis on the fresh growth opportunities, trends and growth drivers that are closely linked with the growth of the market. The report further provides crucial insights on the COVID-19 impacts on the central labs market along with the compound growth rate (CAGR) of the market for a forecasted period between 2022 and 2030. The report also comprises assessment of the market by employing various analytical tools, such as Porter's five forces analysis and PESTEL analysis. These tools also offer an in-depth analysis on the micro and macro-environmental factors that are related to the growth of the market over the projected period.  Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/5962 Reports & Insights Overview The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort. A research report on the Central Labs market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/report/central-labs-market Central Labs Market Segmentatio

One of the day's biggest gainers and biggest losers both came from the healthcare sector on news of a planned buyout and negative results from a clinical trial.

EMA will launch a final round of targeted consultations with key stakeholders on its draft policy on proactive publication of and access to clinical-trial data at the beginning of May 2014.

Medtronic has reported positive data from a retrospective analysis of the ENDURANCE and ENDURANCE Supplemental clinical trials.

Healthcare stocks dominated news on Monday as buy-outs and clinical trials made for some of the day's biggest movers.

Physicians, hospitals, clinical trial users, reimbursement experts, regulators must attend this webinar to learn how FDA regulates molecular diagnostic tests.

The development of significant expense medicines has sped up the speed of conversations about elective installment models that would at the same time empower fast persistent access while guaranteeing manageable medical care spending. Continue Reading: https://bit.ly/3v268uH Reference: https://pubrica.com/services/data-analytics-machine-learning/health-economics-outcome-research/ Why Pubrica: When you order our services, We promise you the following - Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Biostatistical experts | High-quality Subject Matter Experts.   Contact us:      Web: https://pubrica.com/  Blog: https://pubrica.com/academy/  Email: sales@pubrica.com  WhatsApp : +91 9884350006  United Kingdom: +44- 74248 10299

The abstract of an original research manuscript writing article (e.g., clinical trial) published in the biomedical literature is considered a synopsis of the essential principles of the study. The background, purpose, basic methodology, key results, and a general conclusion should be presented within the abstract. Continue Reading: https://bit.ly/3oYUd02 For our services: https://pubrica.com/services/physician-writing-services/ Why Pubrica: When you order our services, we promise you the following - Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Bio statistical experts | High-quality Subject Matter Experts.   Contact us:      Web: https://pubrica.com/  Blog: https://pubrica.com/academy/  Email: sales@pubrica.com  WhatsApp : +91 9884350006  United Kingdom: +44-1618186353

RepliCel, which is currently testing their groundbreaking procedure for treating baldness, has converted 13 million shares of Class C stock into common stock.

The Healthcare sector has been particularly busy in the first month of 2012 with a healthy dose of major acquisitions dominating the news.

While biotech is not an industry for investors who are faint of heart, the potential for big returns can still make it attractive.

Webinar describes about Project portfolio optimization methodology. The art and science in project portfolio optimization for drug development.